Ruijin Hospital

This study tests a personalized treatment approach for people newly diagnosed with marginal zone lymphoma, a slow-growing blood cancer. Researchers will assign treatments based on each patient's risk level, aiming to improve cancer control and reduce side effects. About 145 adult…

This study is testing a combination of three drugs (orelabrutinib, selinexor, and either methotrexate or alternatives) in 25 people with relapsed or refractory central nervous system lymphoma (CNSL), a type of brain cancer that has not responded to prior treatment. The goal is to…

This study tests if a new drug, firsekibart, works better than the current treatment anakinra for adults with Adult-Onset Still's disease (AOSD), a rare inflammatory condition. About 20 participants aged 18-75 will receive either drug to see which controls symptoms and inflammati…

This study tests a combination of drugs (LM-302, S-1, and paclitaxel given into the abdomen, with or without cadonilimab) in people with a specific type of advanced stomach cancer that has spread to the lining of the abdomen. The goal is to see if this treatment helps patients li…

This study tests whether giving chemotherapy plus an immunotherapy drug before surgery can make colon cancer disappear completely in patients with locally advanced disease. About 56 adults with a specific type of colon cancer will receive the treatment combination, followed by st…

This study tests a new approach for people with locally advanced pancreatic cancer whose first chemotherapy stopped working. The treatment combines a procedure that uses electrical pulses to destroy tumor cells (IRE) with an antibody drug that helps the immune system attack the c…

This study is testing an artificial intelligence (AI) system that can recognize different parts of the nose and throat and detect abnormal growths (lesions) from standard camera images. About 500 adults who undergo a routine nose-and-throat exam will have their images used to tra…